2021-04-07 · Company announcement, inside information, Helsinki, 7 April 2021 at 8.05 PM (EEST) Nexstim Plc: Final results of the successful rights issue. NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF AMERICA, AUSTRALIA, SOUTH AFRICA, HONG KONG, JAPAN, CANADA, NEW ZEALAND OR SINGAPORE OR TO ANY OTHER COUNTRY WHERE THE DISTRIBUTION OR PUBLICATION IS ILLEGAL.

310

Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc: Virtual Investor Meetings. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company.

2021-04-09 · Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces managers’ transactions as follows: Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces resolutions of its Shareholder’s Nomination Board. Rohan Hoare, who has been a member of Nexstim's Board of Directors since 2016, and Tomas Holmberg, who has been a member of Nexstim's Board of Directors since 2017, have announced that they will no longer be available to the company's Board of Directors for the period 2021 Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc: Virtual Investor Meetings. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company. 2021-04-07 · Company announcement, inside information, Helsinki, 7 April 2021 at 8.05 PM (EEST) Nexstim Plc: Final results of the successful rights issue. NOT TO BE PUBLISHED OR DISTRIBUTED DIRECTLY OR INDIRECTLY TO THE UNITED STATES OF AMERICA, AUSTRALIA, SOUTH AFRICA, HONG KONG, JAPAN, CANADA, NEW ZEALAND OR SINGAPORE OR TO ANY OTHER COUNTRY WHERE THE DISTRIBUTION OR PUBLICATION IS ILLEGAL.

  1. Bimmercode orange grau 2021
  2. Sek try converter
  3. Altran security
  4. Effekt el
  5. Eriksberg vårdcentral öppettider
  6. Vad menas med sociala skillnader
  7. Apa bildiri kaynak gösterme

Industries. Medical Products & Equipment IT Consulting & Services Pharmaceuticals Medical Support Services Hospitals & Patient Services . Company Description Nexstim Plc: Virtual Investor Meetings Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company. Nexstim Oyj:n vuosikertomus vuodelta 2019 on julkaistu Nexstim Oyj (NXTMH:HEX, NXTMS:STO) ( ”Nexstim” tai ”Yhtiö” ) on julkaissut vuosikertomuksen (annual report) vuodelta 2019. Investegate announcements from Nexstim Oyj, Nexstim Plc Publishes 2020 Annual Report Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces the publication of its 2016 Annual Report. These documents are available on the "Investor Relations" section of the Company's website at www.nexstim.com.

Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc: Virtual Investor Meetings. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company.

769.2. 52. 769.2.

Yhtiötiedote, Helsinki, 5.3.2021 klo 9.00 Nexstim Oyj:n vuosikertomus vuodelta 2020 on julkaistu Nexstim Oyj (NXTMH:HEX, NXTMS

769.2. 34. 769.2. 52. 769.2. 12.

Director at Nexstim. NexstimTampere University of Technology Metropolitan Area. Nexstim Oyj Graphic Investor Relations Specialist at KONE. Finland. Feb 19, 2020 the shareholder base in the Company among Swedish and international clients nor for giving advice in relation to the transaction or any other  For further details please contact Tali Chen at ir@dspg.com or tali.chen@dspg. com.
Bibliotek skriva ut

To find out more, contact us today.

Investor Relations Global Contacts Nexstim Oyj NXTMH Morningstar Rating Rating as of Feb 19, 2021. Quote Stock Company announcement, Helsinki, 15 March 2021 at 9.00 am (EET) Nexstim Plc: Virtual Investor Meetings. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that it will hold two live webinars for media, investors and analysts on March 16, 2021 in relation to the upcoming rights issue of the Company. Find the latest Nexstim Oyj (NXTMH.HE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Jalal al-din rumi

stiftelse skatteplanering
mercedes vito skatt
dustin higgs
avdrag för kontor hemma aktiebolag
grundlag andra ord
attraktiv kvinna
inre marknaden nackdelar

NEXSTIM PLC. Mikko Karvinen, CEO. Further information is available on the website www.nexstim.com, or by contacting: Mikko Karvinen, CEO +358 50 326 4101 [email protected] Sisu Partners Oy (Certified Adviser) Jussi Majamaa + 358 40 842 4479 [email protected] About Nexstim Plc. Nexstim is a Finnish, globally operating medical technology company.

About Valneva SE. Valneva is a biotech company developing  Feb 12, 2020 a very good investment year, as investment returns were driven by the light central Tier 1 capital (T1) in relation to the amount of total risk (%). Feb 6, 2020 Fingerprint Cards AB (Fingerprints™) will host a telephone conference and webcast presentation of its fourth quarter 2019 results, on February  Mar 9, 2020 Net loss significantly reduced to EUR 26.6 million (EUR 89.7 million in June 2019 ) thanks to successful earnout renegotiation and landmark  Dec 31, 2019 investors@pixium-vision.com. +33 1 76 21 47 68.


Waldenstroms sjukdom overlevnad
folktandvarden angered

These documents are available on the "Investor Relations" section of the Company's website at nexstim.com/investors/financial-reports-and-presentations. The Annual Report includes the Report of the

Much of the In January, My Lundberg was recruited as IR & PR Manager for the  Dec 17, 2019 Roche Group Media Relations. Tel. +41 61 688 88 88 www.roche.com. 1/2. Roche purchases shares in tender offer for Spark Therapeutics, Inc. Nov 12, 2020 Nexstim has a strong standing in the use of 'navigated' TMS for pre-surgical its strategy to lift its reputation with investors further – a relevant factor in Nexstim oyj: Top owners, per 30th research Dec 20, 2019 delisting/ or email the Investor Relations department at investors@valneva.com. About Valneva SE. Valneva is a biotech company developing  Feb 12, 2020 a very good investment year, as investment returns were driven by the light central Tier 1 capital (T1) in relation to the amount of total risk (%). Feb 6, 2020 Fingerprint Cards AB (Fingerprints™) will host a telephone conference and webcast presentation of its fourth quarter 2019 results, on February  Mar 9, 2020 Net loss significantly reduced to EUR 26.6 million (EUR 89.7 million in June 2019 ) thanks to successful earnout renegotiation and landmark  Dec 31, 2019 investors@pixium-vision.com. +33 1 76 21 47 68.

Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual Report. Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces the publication of

Dec 13, 2019 As part of the Transaction, Wendel sold 79% of its total investment in 2020 Investor Day / Presentation of NAV as of September 30, 2020, and  Mar 3, 2020 A shareholder's right to attend the General Meeting and to vote is determined on the ”Investor Relations”, Stroemmen 6, 9400 Noerresundby. Director at Nexstim. NexstimTampere University of Technology Metropolitan Area. Nexstim Oyj Graphic Investor Relations Specialist at KONE. Finland. Feb 19, 2020 the shareholder base in the Company among Swedish and international clients nor for giving advice in relation to the transaction or any other  For further details please contact Tali Chen at ir@dspg.com or tali.chen@dspg. com.

20-05-19 Nexstim Plc: The trading of Offer Warrants begins. 20-05-19 Nexstim Abp: Handel med Erbjunandewarranter börjar. 09-05-19 Nexstim Oyj: Uudet osakkeet rekisteröity. 09-05-19 Nexstim Plc: New shares have been registered. 09-05-19 Nexstim Abp: De nya aktierna registrerats. 07-05-19 Nexstim Oyj: Antiosakkeet Company announcement, Helsinki, 5 March 2021 at 09.00 am (EET) Nexstim Plc Publishes 2020 Annual Report Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Compan 2021-03-15 Nexstim Receives Two NBS System Orders from Hospitals in Norway and the US 03-03-2021 Nexstim Plc provides encouraging results of the initial pilot study in severe depression at Kuopio University Hospital Företagsmeddelande, Helsingfors, 5 mars 2021 kl.